Alliance for Clinical Trials in Oncology
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation
- Conditions
- Non-melanomatous Skin Cancer
- Interventions
- Drug: acitretinOther: placebo
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 129
- Registration Number
- NCT00003611
- Locations
- πΊπΈ
CentraCare Health Plaza, Saint Cloud, Minnesota, United States
πΊπΈCCOP - Wichita, Wichita, Kansas, United States
πΊπΈCCOP - Carle Cancer Center, Urbana, Illinois, United States
Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-08-12
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 633
- Registration Number
- NCT00024102
- Locations
- π¨π¦
Mount Sinai Hospital - Toronto, Toronto, Ontario, Canada
πΊπΈUSC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
πΊπΈKimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
- Conditions
- Esophageal CancerGastric Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 48
- Registration Number
- NCT00040859
- Locations
- πΊπΈ
Mercy Medical Center - Sioux City, Sioux City, Iowa, United States
πΊπΈSiouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States
πΊπΈAvera Cancer Institute, Sioux Falls, South Dakota, United States
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 58
- Registration Number
- NCT00005601
- Locations
- πΊπΈ
CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
πΊπΈCCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States
πΊπΈCCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 25
- Registration Number
- NCT00006010
- Locations
- πΊπΈ
CCOP - Atlanta Regional, Atlanta, Georgia, United States
πΊπΈCCOP - Carle Cancer Center, Urbana, Illinois, United States
πΊπΈSiouxland Hematology-Oncology, Sioux City, Iowa, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 48
- Registration Number
- NCT00026403
- Locations
- πΊπΈ
Altru Cancer Center, Grand Forks, North Dakota, United States
πΊπΈAllegheny General Hospital, Pittsburgh, Pennsylvania, United States
πΊπΈMayo Clinic Cancer Center, Rochester, Minnesota, United States
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 41
- Registration Number
- NCT00041054
- Locations
- πΊπΈ
Broward General Medical Center, Fort Lauderdale, Florida, United States
πΊπΈMBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States
πΊπΈVeterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
Positron Emission Tomography in Determining Stage of Esophageal Cancer
- Conditions
- Esophageal Cancer
- Interventions
- Procedure: conventional surgeryProcedure: positron emission tomographyProcedure: radionuclide imagingRadiation: fludeoxyglucose F 18Drug: chemotherapyRadiation: Radiotherapy
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 235
- Registration Number
- NCT00004867
- Locations
- πΊπΈ
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
πΊπΈCancer Center at Greater Baltimore Medical Center, Baltimore, Maryland, United States
πΊπΈArthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States
EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 226
- Registration Number
- NCT00046891
- Locations
- πΊπΈ
Graham Hospital, Canton, Illinois, United States
πΊπΈSt. John Macomb Hospital, Warren, Michigan, United States
πΊπΈHurley Medical Center, Flint, Michigan, United States
Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
- Conditions
- Breast Cancer
- Interventions
- Procedure: biopsyProcedure: magnetic resonance imagingProcedure: radiomammographyProcedure: ultrasound imagingRadiation: gadopentetate dimeglumineDrug: chemotherapy
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 360
- Registration Number
- NCT00033397
- Locations
- πΊπΈ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
πΊπΈMasonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
πΊπΈUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States